Lyell Historical Income Statement
| LYEL Stock | USD 0.95 0.03 3.26% |
Historical analysis of Lyell Immunopharma income statement accounts such as Interest Expense of 2.6 M can show how well Lyell Immunopharma performed in making a profits. Evaluating Lyell Immunopharma income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Lyell Immunopharma's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Lyell Immunopharma latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Lyell Immunopharma is a good buy for the upcoming year.
Lyell |
About Lyell Income Statement Analysis
Lyell Immunopharma Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Lyell Immunopharma shareholders. The income statement also shows Lyell investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Lyell Immunopharma Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts Lyell Immunopharma generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Lyell Immunopharma. It is also known as Lyell Immunopharma overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Income Before Tax
Income Before Tax which can also be referred as pre-tax income is reported on Lyell Immunopharma income statement and is an important metric when analyzing Lyell Immunopharma profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Lyell Immunopharma financial statement analysis. It represents the amount of money remaining after all of Lyell Immunopharma operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Most accounts from Lyell Immunopharma's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Lyell Immunopharma current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lyell Immunopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For more information on how to buy Lyell Stock please use our How to buy in Lyell Stock guide.At this time, Lyell Immunopharma's Net Interest Income is quite stable compared to the past year. Interest Income is expected to rise to about 24.6 M this year, although the value of Total Revenue will most likely fall to about 123.5 K.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Income | 1.2M | 7.1M | 23.5M | 24.6M | Net Interest Income | 1.2M | 7.1M | 23.5M | 24.6M |
Lyell Immunopharma income statement Correlations
Click cells to compare fundamentals
Lyell Immunopharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lyell Immunopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For more information on how to buy Lyell Stock please use our How to buy in Lyell Stock guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lyell Immunopharma. If investors know Lyell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lyell Immunopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.79) | Quarterly Revenue Growth 0.36 | Return On Assets (0.19) | Return On Equity (0.33) |
The market value of Lyell Immunopharma is measured differently than its book value, which is the value of Lyell that is recorded on the company's balance sheet. Investors also form their own opinion of Lyell Immunopharma's value that differs from its market value or its book value, called intrinsic value, which is Lyell Immunopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lyell Immunopharma's market value can be influenced by many factors that don't directly affect Lyell Immunopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lyell Immunopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lyell Immunopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lyell Immunopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.